Issue · Healthcare

Healthcare (Substance Abuse)

Every healthcare bill, vote, and legislator stance in United States, automatically classified by Maddy, our AI policy reader.

Total bills
186
119th Congress
Top supporter
-
no data yet
Top opponent
-
no data yet
Ranked legislators
0
0 support · 0 oppose
Showing 151–160 of 186 bills

All healthcare bills

in committee · United States · Senate Mar 26, 2025

S 1132: Families Care Act

The Families Care Act amends the Older Americans Act to improve support for family caregivers. It adds peer support services alongside counseling for caregivers and requires states to specifically consider the needs of children caring for older relatives affected by substance use disorders, including opioid addiction. The bill also changes reporting requirements so the Assistant Secretary must regularly publish and disseminate program information instead of making it available by specific deadlines. This directly affects family caregivers, particularly those navigating complex situations involving elder care and substance use. The changes aim to make support services more responsive to diverse caregiver circumstances.
in committee · United States · Senate Feb 6, 2025

S 475: Alternatives to PAIN Act

S 475, the Alternatives to PAIN Act, changes Medicare Part D coverage to make non-opioid pain management drugs more accessible and affordable for beneficiaries. It requires Medicare plans to cover qualifying non-opioid pain drugs without deductibles and place them on the lowest cost-sharing tier (meaning patients pay the least out-of-pocket) starting in 2026. The bill also prohibits plans from requiring step therapy (forcing patients to try opioids first) or prior authorization for these specific drugs. Qualifying drugs must treat acute pain (like post-surgery), not work on opioid receptors, have no equivalent alternatives, and meet cost thresholds. This directly affects Medicare Part D beneficiaries needing pain management and the plans that cover them.
in committee · United States · Senate Jul 17, 2025

S 2332: ALERT Communities Act

The ALERT Communities Act (S 2332) provides federal funding to help states and tribes distribute fentanyl and xylazine test strips to prevent overdose deaths, directly affecting communities and healthcare providers working on opioid crises. It expands grant programs under the 21st Century Cures Act to cover test strips, requires first responder training on using them, and mandates the development of research frameworks for improving test strip technology. The bill also directs the Health Secretary to study how test strip availability impacts overdose rates and treatment engagement, with a report due to Congress within two years. These provisions aim to make overdose prevention tools more accessible through concrete policy changes.
Sub-Topics Substance Abuse
in committee · United States · House Apr 28, 2025

HR 3032: Expanding Remote Monitoring Access Act

This bill changes Medicare billing rules for remote monitoring services, allowing providers to bill for a minimum of 2 days of patient data collected over a 30-day period instead of the current 16 days. It directly affects Medicare patients with chronic conditions (like diabetes, heart failure, or post-surgery recovery) and healthcare providers who use remote monitoring tools. The key provision eliminates the 16-day requirement for all patients - not just during the pandemic - based on clinical evidence showing shorter monitoring periods are sufficient for many conditions. The bill also requires a report to Congress within one year analyzing the impact and recommending future reimbursement models. This aims to reduce administrative barriers while maintaining coverage for clinically appropriate remote monitoring.
in committee · United States · Senate Sep 18, 2025

S 2889: Protecting Student Athletes from Concussions Act of 2025

This bill requires public schools receiving federal education funds to implement concussion safety protocols. Schools must develop plans including staff training, visible posting of evidence-based concussion information, immediate removal from activities if a concussion is suspected, and written medical clearance before returning to sports. It also mandates academic accommodations like modified assignments and cognitive rest during recovery, applying to all students regardless of where a concussion occurred. States failing to comply face reduced federal education funding (5% the first year, 10% thereafter). The law directly affects public school students, athletes, and school staff across all grade levels.
in committee · United States · Senate Jun 18, 2025

S 2121: SUPPORT for Patients and Communities Reauthorization Act of 2025

This bill reauthorizes and expands federal programs addressing the opioid crisis and related health issues through 2030, with increased funding for prevention, treatment, and recovery services. It provides specific funding increases for programs including prenatal and postnatal health services, fetal alcohol spectrum disorder prevention, first responder training, and community-based recovery centers. Key provisions include enhanced cybersecurity protections for suicide prevention hotlines, requirements for reporting on program effectiveness, and expanded support for individuals with substance use disorders through workforce development and peer support services. The bill directly affects healthcare providers, public health agencies, community organizations, and individuals seeking treatment for substance use disorders.
in committee · United States · Senate Mar 14, 2025

S 1074: Agricultural Access to Substance Use Disorder Treatment and Mental Health Care Act of 2025

S 1074, the *Agricultural Access to Substance Use Disorder Treatment and Mental Health Care Act of 2025*, mandates a study on mental health and substance use disorder care access for farmers, ranchers, and agricultural workers. The Comptroller General will examine rural availability of specialized providers, barriers like cost or geography, and effective programs (such as telehealth or cultural training) to inform future policy. The study’s findings will be submitted to key congressional committees and federal agencies, including Agriculture and Health and Human Services, to guide potential improvements in care accessibility for agricultural communities. This procedural bill does not create new programs but focuses on gathering data to address existing gaps.
Sub-Topics Mental Health Substance Abuse Telehealth Tags Agriculture Rural Communities
in committee · United States · Senate Nov 6, 2025

S 3134: Combating Counterfeit Pharmaceuticals Act of 2025

This bill defines "copy-cat ingredients" as substances mimicking approved drugs but made via different processes or with lower quality, and clarifies "counterfeit drugs" under existing law. It updates the Fentanyl Sanctions Act to replace all references to "opioid" with "illicit drug," expanding the law's scope to cover all counterfeit pharmaceuticals - not just opioid-related products. The bill also adds a waiver allowing access to medications on the HHS drug shortage list. These changes help regulators and law enforcement better identify and address counterfeit drugs affecting patients and the healthcare system.
in committee · United States · Senate Oct 23, 2025

S 3048: TREATS Act

The TREATS Act amends the Controlled Substances Act to allow telehealth evaluations as an alternative to in-person medical evaluations for prescribing certain controlled substances. Specifically, it permits one telehealth evaluation (conducted via real-time audio/video systems meeting Social Security Act standards) instead of an in-person visit when prescribing FDA-approved medications for substance use disorder treatment (schedules III-V). This directly affects healthcare providers who prescribe these medications, expanding their ability to use telehealth for initial patient assessments. The change maintains the requirement for at least one evaluation (either in-person or telehealth) while updating the process to include telehealth options for this specific treatment context.
in committee · United States · Senate Nov 19, 2025

S 3209: NOPAIN for Veterans Act

S 3209, the NOPAIN for Veterans Act, requires the Department of Veterans Affairs (VA) to include non-opioid pain medications in its national formulary for veterans. The bill defines "non-opioid pain management drugs" as FDA-approved treatments for acute pain that don't use opioid receptors. The VA must add these drugs within one year of FDA approval or eligibility for payment under federal health programs, whichever comes first. This policy change directly affects veterans receiving VA pain management care by expanding access to non-opioid options, while prohibiting use of the Cost of War Toxic Exposures Fund to implement this provision.
Showing 151 to 160 of 186 bills
Previous 1 … 15 16 17 … 19 Next